Benchmark Financial Wealth Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,752
Closed -$15.7K 75
2023
Q1
$15.7K Hold
10,752
0.01% 69
2022
Q4
$13.4K Hold
10,752
0.01% 70
2022
Q3
$20K Sell
10,752
-32,750
-75% -$77.4K 0.01% 68
2022
Q2
$110K Sell
43,502
-5,000
-10% -$14.6K 0.06% 71
2022
Q1
$167K Hold
48,502
0.07% 76
2021
Q4
$233K Hold
48,502
0.1% 64
2021
Q3
$177K Hold
48,502
0.08% 66
2021
Q2
$196K Hold
48,502
0.09% 66
2021
Q1
$208K Buy
48,502
+5,000
+11% +$23.9K 0.11% 57
2020
Q4
$172K Sell
43,502
-2,062
-5% -$8.61K 0.09% 66
2020
Q3
$168K Buy
45,564
+25,564
+128% +$108K 0.11% 60
2020
Q2
$68K Buy
+20,000
New +$44.8K 0.05% 55

Other funds holding OPK

Benchmark Financial Wealth Advisors's OPK Position: Q2 2023 in Review

Benchmark Financial Wealth Advisors sold out of Opko Health (OPK) in Q2 2023, closing a stake of 10,752 shares — an estimated $15.7K sold.

Benchmark Financial Wealth Advisors first reported a position in OPK in Q2 2020 and held it in 12 quarters. The position peaked at $233K in Q4 2021. 230 funds tracked by Wall St. Rank hold OPK as of Q2 2023.

  • Benchmark Financial Wealth Advisors reported no remaining Opko Health position as of Q2 2023 after selling out during the quarter.
  • Benchmark Financial Wealth Advisors sold 10,752 Opko Health shares in Q2 2023, an estimated $15.7K.
  • Benchmark Financial Wealth Advisors first reported a position in Opko Health in Q2 2020 and held it in 12 quarters.
  • Benchmark Financial Wealth Advisors's Opko Health position peaked at $233K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Opko Health as of Q2 2023.

Based on Benchmark Financial Wealth Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.